Skip to main content

Positive Association Between 25-Hydroxyvitamin D and C-Reactive Protein is Confounded by Hormonal Contraceptive Use.

García-Bailo B, Josse AR, Jamnik J, Badawi A, El-Sohemy A

Publication: J Womens Health (Larchmt) (2013) • Vol 22 • Page 417-25PMID: 23659482View on PubMed

Purpose

The purpose of this paper was to determine the effects of patient hormonal contraceptive (HC) use, ethnicity, and gender on levels of C-reactive protein (CRP) and 25-hydroxyvitamin D (25(OH)D) in plasma.

Conclusion

The levels of 25(OH)D and CRP in plasma were significantly higher among specimens from women who used HC than those from women who did not use HC or from men. 25(OH)D levels were very weakly correlated with CRP levels, but after accounting for HC use and dose, there were no associations between levels of the two analytes.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient HC use, ethnicity, and gender on levels of CRP and 25(OH)D in plasma.

Summary of Findings

The levels of 25(OH)D and CRP in plasma were significantly higher among specimens from women who used HC than women who did not use HC (p=0.26 and p<0.0001, respectively) and were also higher than levels found in specimens from men (both p<0.0001). Plasma from Caucasian and South Asian men contained intermediate levels of CRP compared to specimens from women HC users and non-users while plasma from East Asian men contained CRP levels that were not statistically different from women not taking HC. 25(OH)D levels were very weakly correlated with CRP levels, but after accounting for HC use and dose, there were no associations between levels of the two analytes, revealing that HC use is a confounding variable in the association between 25(OH)D and CRP levels in plasma.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
  • Platforms

    ProteinClinical chemistry/auto analyzer
    Small moleculeHPLC-MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionOther drugs
    1 mg or more hormonal contraceptives
    < 1 mg hormonal contraceptives
    No hormonal contraceptives
    PreaquisitionPatient gender
    Female
    Male
    PreaquisitionPatient race
    Caucasian
    East Asian
    South Asian